Background Reduced-antigen-content tetanus, diphtheria, and acellular pertussis (Tdap)
vaccine is recommended in many countries for boosting immunity in adolescents and adults …

Annual vaccination with trivalent influenza vaccine (TIV), and a single dose of tetanus toxoid-
reduced diphtheria toxoid-acellular pertussis (Tdap) vaccine, are both recommended for …

This randomized trial enrolled 442 infants in the Republic of Korea to assess the
immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and …

This study evaluated the safety and immunogenicity of combined diphtheria, tetanus,
acellular pertussis, inactivated poliomyelitis vaccine (DTPa-IPV) given as primary …

In view of the continuing risk of contracting tetanus, diphtheria and poliomyelitis, and the well-
documented decline in immunity with time, the need for booster vaccinations is substantial …

Pertussis is a highly contagious disease, for which periodic peaks in incidence and an
increasing number of outbreaks have been observed over the last decades. The reduced …

PURPOSE: This study was conducted to assess the immunogenicity and safety of a tetanus
toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine containing three …

Introduction This follow-up study assessed the 5-year persistence of vaccine-induced
antibodies (Td-IPV or DT-IPV) and the immune response to a booster dose of DTaP-IPV …

An understanding of the antibody persistence elicited by a combined tetanus, diphtheria, 5-
component acellular pertussis, and inactivated poliovirus vaccine (Tdap-IPV) after …

BACKGROUND: Pertussis can cause significant morbidity in elderly patients, who can also
transmit this disease to infants and young children. There is little data available on the use of …